Latest News

Issue of Equity on Exercise of Warrants

22 October 2020

London, New York, 22 October 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and...

Read more

Exercise of options, Issue of Equity PDMR Dealing and Total Voting Rights

21 October 2020

London, New York, 21 October 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and...

Read more

Issue of Equity on Exercise of Warrants

20 October 2020

London, New York, 20 October 2020 - Tiziana Life Sciences plc (Nasdaq: TLSA / AIM: TILS) ("Tiziana" or the "Company"), a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that it has allotted and...

Read more

Result of General Meeting

02 October 2020

At the General Meeting of the Company held at 11.00 a.m. on 2 October 2020, both of the resolutions were duly passed.

The anticipated timetable for the demerger of Accustem Sciences Limited (to be re-registered as Accustem Sciences Plc) is as...

Read more

Interim Results for the Six Months Ended 30 June 2020

30 September 2020

London, 30 September 2020 – Tiziana Life Sciences plc (“Tiziana”, AIM: TILS, NASDAQ: TLSA), a biotechnology company that focuses on the discovery and development of novel molecules to treat human diseases in oncology, inflammation and infectious diseases today announces its interim results for the six months ended 30 June 2020.

Read more

Tiziana Life Sciences Interview to Air on Bloomberg International on the RedChip Money Report

25 September 2020

Tiziana Life Sciences Interview to Air on Bloomberg International on the RedChip Money Report

Read more

Page 1 of 21 Next